Ofatumumab plus chlorambucil versus chlorambucil alone in patients with untreated chronic lymphocytic leukaemia (CLL): results of the phase III study COMPLEMENT 1 (OMB110911; NCRN-adopted)

Ofatumumab plus chlorambucil versus chlorambucil alone in patients with untreated chronic lymphocytic leukaemia (CLL): results of the phase III study COMPLEMENT 1 (OMB110911; NCRN-adopted)

Bibliográfalaš dieđut
Váldodahkkit:	Hillmen, P, Pettitt, A, Schuh, A, Milligan, D, Bowles, K, Bareford, D, Riaz, J, Follows, G, Rule, S, Wallis, J, Gribben, J, Noble, R, Pocock, C, Lisby, S, Carey, J, Gupta, I, Chang, C, McKeown, A
Materiálatiipa:	Journal article
Almmustuhtton:	2014

Geahča maid

Azathioprine, cyclophosphamide and chlorambucil.
Dahkki: Luqmani, R, et al.
Almmustuhtton: (1990)

UK experience of Ofatumumab in refractory B-CLL
Dahkki: Varghese, A, et al.
Almmustuhtton: (2011)

Chlorambucil-Induced Acute Interstitial Pneumonitis
Dahkki: Hammad Shafqat, et al.
Almmustuhtton: (2014-01-01)

Rapid desensitization for chlorambucil drug fever
Dahkki: E Weber, et al.
Almmustuhtton: (2007-07-01)

Ofatumumab retreatment and maintenance in patients with fludarabine-refractory CLL.
Dahkki: Osterborg, A, et al.
Almmustuhtton: (2012)

UK Medical Research Council CLL3 - A randomized trial of the addition of epirubicin to standard chlorambucil treatment.
Dahkki: Catovsky, D, et al.
Almmustuhtton: (2000)

The Occurrence of Richter’s Syndrome during Treatment with Obinutuzumab and Chlorambucil
Dahkki: Teng Fong Ng, et al.
Almmustuhtton: (2020-01-01)

Chlorambucil-Bearing Hybrid Molecules in the Development of Potential Anticancer Agents
Dahkki: Sijongesonke Peter, et al.
Almmustuhtton: (2023-09-01)

Long-term management of a cat with nasopharyngeal lymphoma by chlorambucil
Dahkki: Kaho Takahashi, et al.
Almmustuhtton: (2021-04-01)

Chlorambucil combination therapy in refractory serpiginous choroiditis: A cure?
Dahkki: Arash Maleki, et al.
Almmustuhtton: (2021-03-01)

Synthesis, Characterization, and Cytotoxicity Evaluation of Chlorambucil-Functionalized Mesoporous Silica Nanoparticles
Dahkki: Juliana Camila Fischer Karnopp, et al.
Almmustuhtton: (2024-08-01)

Chlorambucil-Loaded Graphene-Oxide-Based Nano-Vesicles for Cancer Therapy
Dahkki: Surabhi Kumari, et al.
Almmustuhtton: (2023-02-01)

Chlorambucil targets BRCA1/2‐deficient tumours and counteracts PARP inhibitor resistance
Dahkki: Tacconi, E, et al.
Almmustuhtton: (2019)

Combination of Chlorambucil and Mercaptopurine Show Effective Anti-Cancer Effects in Mice Model
Dahkki: Xu W, et al.
Almmustuhtton: (2023-12-01)

Nasal Lymphoma with Low Mitotic Index in Three Cats Treated with Chlorambucil and Prednisolone
Dahkki: Karen W. L. Ng, et al.
Almmustuhtton: (2022-09-01)

Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab in chronic lymphocytic leukemia
Dahkki: Othman Al-Sawaf, et al.
Almmustuhtton: (2023-04-01)

Growth arrest of BCR-ABL positive cells with a sequence-specific polyamide-chlorambucil conjugate.
Dahkki: C James Chou, et al.
Almmustuhtton: (2008-01-01)

In vitro effect of chlorambucil on human glioma cell lines (SF767 and U87-MG), and human microvascular endothelial cell (HMVEC) and endothelial progenitor cells (ECFCs), in the context of plasma chlorambucil concentrations in tumor-bearing dogs.
Dahkki: Michael J Reese, et al.
Almmustuhtton: (2018-01-01)

Chlorambucil-iron oxide nanoparticles as a drug delivery system for leukemia cancer cells
Dahkki: Al-Ali, Samer Hasan Hussein, et al.
Almmustuhtton: (2021)

Retrospective Safety Evaluation of Combined Chlorambucil and Toceranib for the Treatment of Different Solid Tumours in Dogs
Dahkki: Yuk-Yin Lai, et al.
Almmustuhtton: (2024-11-01)

Kolaviron and L-Ascorbic Acid Attenuate Chlorambucil-Induced Testicular Oxidative Stress in Rats
Dahkki: Ebenezer Tunde Olayinka, et al.
Almmustuhtton: (2014-01-01)

Chlorambucil targets BRCA1/2‐deficient tumours and counteracts PARP inhibitor resistance
Dahkki: Eliana MC Tacconi, et al.
Almmustuhtton: (2019-05-01)

Lenalidomide can be safely combined with chlorambucil and rituximab in older patients with chronic lymphocytic leukemia
Dahkki: Candida Vitale, et al.
Almmustuhtton: (2019-01-01)

Nanocarrier systems loaded with IR780, iron oxide nanoparticles and chlorambucil for cancer theragnostics
Dahkki: Phuong-Thao Dang-Luong, et al.
Almmustuhtton: (2024-02-01)

Successful rescue treatment using chlorambucil for presumed recurrence of sinonasal lymphoma in a cat
Dahkki: Sho Goto, et al.
Almmustuhtton: (2023-03-01)

Discovery of a potent olaparib–chlorambucil hybrid inhibitor of PARP1 for the treatment of cancer
Dahkki: Hongyu Qin, et al.
Almmustuhtton: (2023-01-01)

Biochemical and pathological studies on the effects of levamisole and chlorambucil on Ehrlich ascites carcinoma-bearing mice
Dahkki: Fakhry S. Salem, et al.
Almmustuhtton: (2011-01-01)

In vivo antitumor activity study of targeted chlorambucil-loaded nanolipid carrier for breast cancer
Dahkki: Ameer S. Sahib, et al.
Almmustuhtton: (2022-07-01)

Chlorambucil-Iron Oxide Nanoparticles as a Drug Delivery System for Leukemia Cancer Cells
Dahkki: Hussein-Al-Ali SH, et al.
Almmustuhtton: (2021-09-01)

Economic evaluation of obinutuzumab in combination with chlorambucil in first-line treatment of patients with chronic lymphocytic leukemia in Spain
Dahkki: Casado LF, et al.
Almmustuhtton: (2016-09-01)

Obinutuzumab plus chlorambucil versus ibrutinib in previously untreated chronic lymphocytic leukemia patients without TP53 disruptions: A real-life CLL campus study
Dahkki: Andrea Visentin, et al.
Almmustuhtton: (2022-11-01)

Chlorambucil and fludarabine as a new pre-transplant conditioning for patients with chronic lymphocytic leukemia: results of in vivo experiments
Dahkki: J. Tomenendalova, et al.
Almmustuhtton: (2008-10-01)

Author Correction: Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab in chronic lymphocytic leukemia
Dahkki: Othman Al-Sawaf, et al.
Almmustuhtton: (2023-10-01)

Fluorometric and Docking Analysis of the Complex Formation between an Anti-Cancer Drug, Chlorambucil and Bovine Serum Albumin
Dahkki: Saufi, Aimi Nabila Mohamad, et al.
Almmustuhtton: (2019)

Chlorambucil effect on B lymphocites in the peripheral blood of patients with chronic lymphocytic leukemia: Cell ultrastructure investigation
Dahkki: Brajušković Goran R., et al.
Almmustuhtton: (2003-01-01)

Chlorambucil Conjugated Ugi Dendrimers with PAMAM-NH<sub>2</sub> Core and Evaluation of Their Anticancer Activity
Dahkki: Nalin Seixas, et al.
Almmustuhtton: (2019-02-01)

The interaction of the chemotherapeutic drug chlorambucil with human glutathione transferase A1-1: kinetic and structural analysis.
Dahkki: Michael Karpusas, et al.
Almmustuhtton: (2013-01-01)

P666: ACALABRUTINIB ± OBINUTUZUMAB VS OBINUTUZUMAB + CHLORAMBUCIL IN TREATMENT-NAIVE CHRONIC LYMPHOCYTIC LEUKEMIA: 5-YEAR FOLLOW-UP OF ELEVATE-TN
Dahkki: J. P. Sharman, et al.
Almmustuhtton: (2022-06-01)

Rituximab plus bendamustine or chlorambucil for chronic lymphocytic leukemia: primary analysis of the randomized, open-label MABLE study
Dahkki: Anne-Sophie Michallet, et al.
Almmustuhtton: (2018-04-01)

pH-triggered dynamic erosive small molecule chlorambucil nano-prodrugs mediate robust oral chemotherapy
Dahkki: Xin Liu, et al.
Almmustuhtton: (2023-07-01)